Search

Your search keyword '"Morgillo A"' showing total 1,608 results

Search Constraints

Start Over You searched for: Author "Morgillo A" Remove constraint Author: "Morgillo A"
1,608 results on '"Morgillo A"'

Search Results

1. Detecting Markovianity of Quantum Processes via Recurrent Neural Networks

2. Quantum optical classifier with superexponential speedup

3. Spectral Gap Superposition States

6. Behavioural components and delivery features of early childhood obesity prevention interventions: intervention coding of studies in the TOPCHILD Collaboration systematic review

7. Quantum State Reconstruction in a Noisy Environment via Deep Learning

8. New perspectives on inoperable early-stage lung cancer management: Clinicians, physicists, and biologists unveil strategies and insights

9. DNA-PK inhibition sustains the antitumor innate immune response in small cell lung cancer

14. Evaluation of a menu box delivery service for Australian long-day care services to improve food provision and child intake: a cluster randomised controlled trial

15. Development of an initiatives package to increase children’s vegetable intake in long day care centres using the Multiphase Optimisation Strategy (MOST) randomised factorial experiment

17. Activity of osimeRTInib in non-small-cell lung Cancer with UNcommon epidermal growth factor receptor mutations: retrospective Observational multicenter study (ARTICUNO)

18. Vedolizumab as Rescue Therapy in Carboplatin-Gemcitabine-Induced Triggered Acute Severe Ulcerative Colitis Flare-Up

22. Evaluation of a long day care intervention targeting the mealtime environment and curriculum to increase children’s vegetable intake: a cluster randomised controlled trial using the multiphase optimisation strategy framework

23. A world-first food service satisfaction questionnaire for use with family members of nursing home residents: expanding the toolkit of valid and reliable aged care food service satisfaction questionnaires

24. Collecting clinical data during an emergency: quality of life in primary biliary cholangitis during the COVID-19 pandemic

25. PBMCs as Tool for Identification of Novel Immunotherapy Biomarkers in Lung Cancer

26. Triple blockade of Ido-1, PD-L1 and MEK as a potential therapeutic strategy in NSCLC

27. Comparative assessment of early mortality risk upon immune checkpoint inhibitors alone or in combination with other agents across solid malignancies: a systematic review and meta-analysis

28. Addition of Bevacizumab to Erlotinib as First-Line Treatment of Patients With EGFR-Mutated Advanced Nonsquamous NSCLC: The BEVERLY Multicenter Randomized Phase 3 Trial

29. Impact of a cardio‐oncology unit on prevention of cardiovascular events in cancer patients

30. Immunotherapy for head and neck cancer: Present and future

31. Behavioural components and delivery features of early childhood obesity prevention interventions: intervention coding of studies in the TOPCHILD Collaboration systematic review.

32. Diagnostic Challenges in the Pathological Approach to Pleural Mesothelioma.

33. Discovery of N-substituted-2-oxoindolin benzoylhydrazines as c-MET/SMO modulators in EGFRi-resistant non-small cell lung cancer.

34. Combined Therapeutic Strategies Based on the Inhibition of Non-Oncogene Addiction to Improve Tumor Response in EGFR- and KRAS-Mutant Non-Small-Cell Lung Cancer.

35. A Definitive Prognostication System for Patients With Thoracic Malignancies Diagnosed With Coronavirus Disease 2019: An Update From the TERAVOLT Registry

36. Evaluation of COVID-19 impact on DELAYing diagnostic-therapeutic pathways of lung cancer patients in Italy (COVID-DELAY study): fewer cases and higher stages from a real-world scenario

37. Frailty as a predictor of mortality in COVID-19 patients receiving CPAP for respiratory insufficiency

38. Anti-tumor activity of cetuximab plus avelumab in non-small cell lung cancer patients involves innate immunity activation: findings from the CAVE-Lung trial

41. Understanding the role of the gut microbiome in gastrointestinal cancer: A review

43. Immunotherapy in advanced Non-Small Cell Lung Cancer patients with poor performance status: The role of clinical-pathological variables and inflammatory biomarkers

45. Immune-Cell-Derived Exosomes as a Potential Novel Tool to Investigate Immune Responsiveness in SCLC Patients: A Proof-of-Concept Study.

46. Chemotherapy-induced neutropenia and treatment efficacy in advanced non-small-cell lung cancer: a pooled analysis of 6 randomized trials

47. Coronavirus Disease 2019 Outcomes, Patient Vaccination Status, and Cancer-Related Delays During the Omicron Wave: A Brief Report From the TERAVOLT Analysis

48. AXL is a predictor of poor survival and of resistance to anti-EGFR therapy in RAS wild-type metastatic colorectal cancer

50. New perspectives on inoperable early-stage lung cancer management: Clinicians, physicists, and biologists unveil strategies and insights

Catalog

Books, media, physical & digital resources